FH and atherosclerosis: These data emphasize the importance of sphingolipid metabolism in the presence of FH pathogenic variants, suggesting a potential role in the increased susceptibility to atherosclerosis observed in FH patients and highlighting SM as potential therapeutic targets to reduce CVD risk.